Charles Schwab Investment Management Inc Nrx Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Nrx Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 43,732 shares of NRXP stock, worth $106,706. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,732
Previous 43,732
-0.0%
Holding current value
$106,706
Previous $20,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NRXP
# of Institutions
34Shares Held
3.74MCall Options Held
64.6KPut Options Held
9.6K-
Vanguard Group Inc Valley Forge, PA1.44MShares$3.51 Million0.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD615KShares$1.5 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA420KShares$1.02 Million0.0% of portfolio
-
Black Rock Inc. New York, NY291KShares$709,3420.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny189KShares$460,6230.0% of portfolio
About NRX Pharmaceuticals, Inc.
- Ticker NRXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,641,296
- Market Cap $165M
- Description
- NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...